Arrowhead Pharmaceuticals

ARWRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$12.381 B

$87.65 +2.12%

Close of 7 Aug 2026

Revenue

$829.4M

#1639 by revenue

Earnings

-$1.63M

Loss-making

Shares outstanding

141,254,467

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#26BridgeBio PharmaBBIO$16.5B
#27Ascendis Pharma A/SASND$15.8B
#28Arrowhead PharmaceuticalsARWR$12.4B
#29Biomarin PharmaceuticalBMRN$12.3B
#30Corcept TherapeuticsCORT$12.0B

Where these numbers come from

Share counts and financials for Arrowhead Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.